The PARP inhibitor olaparib (Lynparza) may confer a long-term survival benefit in women with HER2-negative metastatic breast cancer and a germline BRCA mutation, most notably in the first-line
In a recent study published in the Cell, researchers assessed the role of angiotensin-converting enzyme 2 (ACE2) in the coronavirus disease 2019 (COVID-19) pandemic. Study: Angiotensin-converting enzyme 2—at
Liver Disease: Expert discusses risks and symptoms We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may
Millions of fat Brits could get weight loss drugs like miracle Wegovy jab in push to trim bulging benefits bill and get country back to work UK’s health
Chagas disease affects approximately 6 million people only in Latin America and is one of the leading causes of death in this region. This infectious disease, also called
Scientific evidence shows how the cognitive decline in Alzheimer’s disease (AD) is caused by the buildup of amyloid beta proteins, which promote synaptic malfunction. One of the neuropathological
Nearly two dozen experimental therapies targeting the immune system are in clinical trials for Alzheimer’s disease, a reflection of the growing recognition that immune processes play a key
A new study led by researchers at Harvard Medical School illuminates how the brain becomes aware that there is an infection in the body. Studying mice, the team
EXCLUSIVE: Outrage as Royal College of Obstetricians and Gynaecologists invites organisation which says ‘not all pregnant people are women’ to speak at International Women’s Day event Controversial speaker
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
